BROOKLYN, N.Y. , Feb. 21, 2021 /PRNewswire/ -- New York's Pandemic Response Laboratory (PRL), a leading diagnostic life sciences company founded by Opentrons Labworks Inc., today announced that its scientists have discovered the first case in a New York State resident. Cases of B1.351, which is the South African variant of COVID-19.

At least 10 other cases of the South African variant have been detected across the United States. 

New York City-based PRL has been conducting mass testing in the state since September 2020 and began genomic sequencing three weeks ago to track COVID-19 variants. After the new variant was discovered among New York residents, PRL notified federal, state and local public health officials.

"Not only can the Epidemic Response Laboratory test for COVID-19 quickly, efficiently and cost-effectively, our ability to track variants of concern is a key advantage in the fight against the virus. We are proud and honored to be part of this fight and look forward to bringing Our innovations are available in all fifty states,” said Jonathan Brennan-Badal, CEO of Opentrons.

Key facts

• 使用 Opentrons 專有技術(shù)廣度和深度，PRL 以低成本產(chǎn)生高度準(zhǔn)確的 PCR 測試結(jié)果和下一代病毒基因組測序信息化。 PRL 可在 24 小時(shí)或更短的時(shí)間內(nèi)提供 99% 的 PCR 結(jié)果智能設備，且檢測成本比全國平均檢測成本低 50%。
  
• PRL 正在擴(kuò)大其測序能力，有望滿足公共衛(wèi)生測序需求。
  
• 去年 9 月就此掀開，紐約市選擇 PRL來領(lǐng)導(dǎo)其 COVID-19 測試流程。 PRL 還為其他客戶提供測試服務(wù)今年，包括醫(yī)院系統(tǒng)和大型雇主穩步前行。
  
• Opentrons specializes in manufacturing innovative robotic automation solutions for the healthcare sector. Its products are used in more than 2,000 laboratories in more than 40 countries. 

Contact: Steve Posner, [email protected], 202-841-1926

SOURCE Pandemic Response Laboratory